2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Fanconi anaemia and leukaemia - clinical and molecular aspects.

      British Journal of Haematology

      Acute Disease, Chromosome Breakage, DNA Repair, Fanconi Anemia, complications, genetics, therapy, Genetic Complementation Test, Genetic Therapy, Histocompatibility Testing, Humans, Leukemia, Myeloid, Stem Cell Transplantation

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Fanconi anaemia (FA) is an autosomal recessive chromosomal instability disorder, which is characterized by congenital abnormalities, defective haemopoiesis and a high risk of developing acute myeloid leukaemia and certain solid tumours. It can be caused by mutations in at least eight different genes. Molecular studies have established that a common pathway exists, both between the FA proteins and other proteins involved in DNA damage repair such as NBS1, ATM, BRCA1 and BRCA2. This review summarizes the general clinical and specific haematological features and the current management of FA. Recent molecular advances will also be discussed in the context of the cellular and clinical FA phenotype, with particular emphasis on the haematological aspects of the condition.

          Related collections

          Author and article information

          Journal
          15238138
          10.1111/j.1365-2141.2004.05023.x

          Comments

          Comment on this article